BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 20, 2009
 |  BC Week In Review  |  Company News  |  Deals

Ensemble Discovery, Bristol-Myers deal

Ensemble will use its drug discovery technologies and screen its collection of Ensemblin small molecules to identify compounds against up to eight undisclosed targets from Bristol-Myers....

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >